OEM News, People News

restor3d Moves into Robotics & Navigation with New Leadership Hires

Larry Hazbun was named senior VP of robotics and Kirstin Widding was appointed senior VP of Hip & Knee.

Author Image

By: Sam Brusco

Associate Editor

restor3d has strategically expanded into the field of robotics and navigation by appointing new leaders Larry Hazbun and Kirstin Widding.
 
Hazbun, who was hired as senior VP of robotics, has more than 25 years of R&D leadership across automotive, aerospace, and medical industries. Before restor3d, he was VP of product development for Globus Medical’s imaging, navigation, and robotics business, focusing on navigated and robotic spine surgery.
 
Before that, he had leadership roles at Mako Surgical (later acquired by Stryker) and was instrumental in developing the Mako robotic-assisted surgical platform for total knee, hip, and other orthopedic procedures.
 
Widding, hired as senior VP of Hip & Knee, has experience as a commercial leader in total hip, knee, shoulder, and enabling technologies. She has a proven track record of driving sales growth through impactful integrated marketing, communications, branding, and product solutions.
 
restor3d uses advanced 3D printing tech to create patient-specific implants that match natural human anatomy and offer optimal osseointegration. The company is moving into robotics and navigation for surgical delivery of its patient-specific implants. It hopes to provide a suite of tools for surgeons to perform patient-specific implant procedures using their preferred method of enabling technology.
 
“We welcome the addition of Larry Hazbun, Senior Vice President of Robotics and Kirstin Widding, Senior Vice President of Hip & Knee,” said Ken Gall, restor3d’s chief commercial officer and co-founder. “The addition of robotics and navigation technologies is a natural fit with personalization and a perfect complement to our patient specific implants. By integrating these enabling technologies with our existing 3D-printed patient specific implants and instruments, restor3d is poised to offer a more holistic approach to personalized patient treatment.”
 
In June, the company closed a $55 million Series A funding round, led by Summer Value Partners and existing investors. The company also gained a further $15 million in debt financing led by Trinity Capital.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters